Flexible modeling of the hazard rate and treatment effects in long-term survival studies
Journal Article
Overview
publication date
has subject area
-
Aged
-
Aged, 80 and over
-
Environment and Public Health - Data Interpretation, Statistical
-
Environment and Public Health - Models, Statistical
-
Environment and Public Health - Proportional Hazards Models
-
Environment and Public Health - Proportional Hazards Models
-
Environment and Public Health - Proportional Hazards Models
-
Environment and Public Health - Proportional Hazards Models
-
Environment and Public Health - Survival Analysis
-
Genital Diseases, Male - Prostatic Neoplasms
-
Health Care Evaluation Mechanisms - Data Interpretation, Statistical
-
Health Care Evaluation Mechanisms - Models, Statistical
-
Health Care Evaluation Mechanisms - Proportional Hazards Models
-
Health Care Evaluation Mechanisms - Proportional Hazards Models
-
Health Care Evaluation Mechanisms - Proportional Hazards Models
-
Health Care Evaluation Mechanisms - Proportional Hazards Models
-
Health Care Evaluation Mechanisms - Survival Analysis
-
Health Care Evaluation Mechanisms - Treatment Failure
-
Health Care Evaluation Mechanisms - Treatment Outcome
-
Health Services Administration - Treatment Failure
-
Health Services Administration - Treatment Outcome
-
Hormones, Hormone Substitutes, and Hormone Antagonists - Androgen Antagonists
-
Humans
-
Investigative Techniques - Data Interpretation, Statistical
-
Investigative Techniques - Data Interpretation, Statistical
-
Investigative Techniques - Models, Statistical
-
Investigative Techniques - Proportional Hazards Models
-
Investigative Techniques - Proportional Hazards Models
-
Investigative Techniques - Proportional Hazards Models
-
Investigative Techniques - Proportional Hazards Models
-
Investigative Techniques - Survival Analysis
-
Male
-
Male Urogenital Diseases - Prostatic Neoplasms
-
Medical Informatics Applications - Data Interpretation, Statistical
-
Middle Aged
-
Models, Theoretical - Models, Statistical
-
Models, Theoretical - Proportional Hazards Models
-
Neoplasm Grading
-
Neoplasms by Site - Prostatic Neoplasms
-
Physiological Effects of Drugs - Androgen Antagonists
-
Prognosis - Treatment Failure
-
Prognosis - Treatment Outcome
-
Prostatic Diseases - Prostatic Neoplasms
has restriction
Date in CU Experts
Full Author List
-
Hagar Y; Dignam JJ; Dukic V
author count
citation count
published in
Other Profiles
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue